Katie Healy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Katie Healy has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- David Wullimann
Karolinska Institutet
2 shared publications - Lotta Hansson
Department of Hematology, Karolinska University Hospital, Stockholm, Sweden
2 shared publications - Margaret Sällberg Chen
Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet , Huddinge
2 shared publications Sandra Muschiol
Department of Clinical Microbiology, Karolinska University Hospital Solna, Stockholm, Sweden
2 shared publications- Yu Gao
Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
2 shared publications Alba Grifoni
11Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA
1 shared publication
Latest Publications
- Open Access
- 27 September 2022
- Published by American Society of Hematology in Blood
- Vol. 140 (22) , 2403-2407
Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination
Blixt Lisa, Yu Gao, David Wullimann, Hanna Murén Ingelman-Sundberg, Sandra Muschiol, Katie Healy, Gordana Bogdanovic, Elisa Pin, Peter Nilsson, Christian Kjella
- 27 September 2022
- Published by American Society of Hematology in Blood
- Vol. 140 (22) , 2403-2407
Open AccessHybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination
Blixt Lisa, Yu Gao, David Wullimann, Hanna Murén Ingelman-Sundberg, Sandra Muschiol, Katie Healy, Gordana Bogdanovic, Elisa Pin, Peter Nilsson, Christian Kjella
- Open Access
- 13 May 2022
- Published by Springer Nature in Molecular Medicine
- Vol. 28 (1) , 1-12
MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine
Mucosa-associated invariant T (MAIT) cells are unconventional T cells with innate-like capacity to rapidly respond to microbial infection via MR1-restricted antigen recognition. Emerging evidence indicate that they can also act as rapid sensors of viral infection via innate cytokine activation. However, their possible role in the immune response to mRNA vaccination is unknown. Here, we evaluated the involvement of MAIT cells in individuals vaccinated with the BNT162b2 mRNA SARS-CoV-2 vaccine. MAIT cell levels, phenotype and function in circulation were preserved and unperturbed through day 35 post-vaccination in healthy donor (HD) vaccinees, as well as people living with HIV (PLWH) or with primary immunodeficiency (PID). Unexpectedly, pre-vaccination and post-vaccination levels of MAIT cells correlated positively with the magnitude of the SARS-CoV-2 spike protein-specific CD4 T cell and antibody responses in the HD vaccinees. This pattern was largely preserved in the PID group, but less so in the PLWH group. Furthermore, in the HD vaccinees levels of MAIT cell activation and cytolytic potential correlated negatively to the adaptive antigen-specific immune responses. These findings indicate an unexpected association between MAIT cell compartment characteristics and the immune response magnitude to the BNT162b2 mRNA vaccine.
- 13 May 2022
- Published by Springer Nature in Molecular Medicine
- Vol. 28 (1) , 1-12
Open AccessMAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine
Mucosa-associated invariant T (MAIT) cells are unconventional T cells with innate-like capacity to rapidly respond to microbial infection via MR1-restricted antigen recognition. Emerging evidence indicate that they can also act as rapid sensors of viral infection via innate cytokine activation. However, their possible role in the immune response to mRNA vaccination is unknown. Here, we evaluated the involvement of MAIT cells in individuals vaccinated with the BNT162b2 mRNA SARS-CoV-2 vaccine. MAIT cell levels, phenotype and function in circulation were preserved and unperturbed through day 35 post-vaccination in healthy donor (HD) vaccinees, as well as people living with HIV (PLWH) or with primary immunodeficiency (PID). Unexpectedly, pre-vaccination and post-vaccination levels of MAIT cells correlated positively with the magnitude of the SARS-CoV-2 spike protein-specific CD4 T cell and antibody responses in the HD vaccinees. This pattern was largely preserved in the PID group, but less so in the PLWH group. Furthermore, in the HD vaccinees levels of MAIT cell activation and cytolytic potential correlated negatively to the adaptive antigen-specific immune responses. These findings indicate an unexpected association between MAIT cell compartment characteristics and the immune response magnitude to the BNT162b2 mRNA vaccine.